Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9713627 Pathogen-inactivated red blood cell compositions

Patent 9713627 was granted and assigned to Cerus on July, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Cerus

Current Assignee

Cerus

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9713627

Date of Patent

July 25, 2017

Patent Application Number

14530415

Date Filed

October 31, 2014

Patent Citations Received

‌

US Patent 12103222 Methods and systems for drawn fused filament fabrication printing

‌

US Patent 11883544 System and methods for implementing a biological fluid treatment device

‌

US Patent 12011510 Biological fluid treatment systems

‌

US Patent 12064537 Kits and methods for preparing pathogen-inactivated platelet compositions

Patent Primary Examiner

‌

Emily Cordas

Patent abstract

The present invention provides pathogen-inactivated red blood cell compositions suitable for infusion into a subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9713627 Pathogen-inactivated red blood cell compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API